J. Schmidt-Lucke

发表

Low frequency flowmotion/(vasomotion) during patho-physiological conditions.

C. Schmidt-Lucke, P. Borgström, J. Schmidt-Lucke, 2002, Life sciences.

Autologous Bone Marrow Cell Transplantation Increases Leg Perfusion and Reduces Amputations in Patients with Advanced Critical Limb Ischemia Due to Peripheral Artery Disease

R. Ratei, J. Schmidt-Lucke, B. Amann, 2009, Cell transplantation.

Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers.

G. Lip, H. Klein, C. Schmidt-Lucke, 2005, International journal of cardiology.

Mesenchymal Stromal Cells Prevent Allostimulation In Vivo and Control Checkpoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation

H. Volk, P. Reinke, C. Tschöpe, 2015, Stem cells.

Local vascular complications after use of the hemostatic puncture closure device Angio-Seal.

C. Kirchhof, C. Schmidt-Lucke, J. Schmidt-Lucke, 2002, VASA. Zeitschrift fur Gefasskrankheiten.

Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial

W. Lehmacher, W. Daniel, P. Hanrath, 2004, Circulation.

Use of subcutaneous enoxaparin compared to intravenous heparin and oral phenprocoumon in the setting of cardioversion--the ACE study (Anticoagulation in Cardioversion using Enoxaparin).

W. Lehmacher, W. Daniel, P. Hanrath, 2003, Cardiac electrophysiology review.

[Hematoma in lipedema: from cutaneous origin or defect of coagulation?]

J. Litmathe, J. Schmidt-Lucke, C. Sucker, 2020, Wiener Medizinische Wochenschrift.

Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.

W. Daniel, H. Klein, P. Hanrath, 2007, Thrombosis Research.

Low molecular weight heparin for prevention of thromboembolic complications in cardioversion – rationale and design of the ACE study (Anticoagulation in Cardioversion using Enoxaparin)

W. Lehmacher, P. Hanrath, U. Nixdorff, 2002, Zeitschrift für Kardiologie.

Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI).

B. Liesenfeld, H. Lawall, J. Schmidt-Lucke, 2008, VASA. Zeitschrift fur Gefasskrankheiten.

Peripheral Artery Physiology and Pathophysiology: Special Considerations

C. Schmidt-Lucke, J. Schmidt-Lucke, 2002 .

Changes of plasma concentrations of soluble vascular cell adhesion molecule-1 and vascular endothelial growth factor after increased perfusion of lower extremities in humans.

H. Klein, C. Schmidt-Lucke, S. Ansorge, 2003, Endothelium : journal of endothelial cell research.

Extremitätenerhalt durch autologe Knochenmarksstammzelltransplantation zur Induktion der Arteriogenese bei kritischer, nicht-revaskularisierbarer Extremitätenischämie

R. Ratei, J. Schmidt-Lucke, C. Lüdemann, 2009, Zentralblatt fur Chirurgie.

Recombinant human GM-CSF in the treatment of poorly healing wounds.

R. Groves, J. Schmidt-Lucke, 2000, Advances in skin & wound care.